UNI-EN 117:Notification under Art. 89t of LPOS regarding public offering of warrants by “Sopharma” AD
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 117 | / | 2021 | |||||||
| Date of issue: | 2021-11-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification under Art. 89t of LPOS regarding public offering of warrants by “Sopharma” AD | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| “Sopharma” AD (the Company) notifies that “Sopharma” AD, with registered office and address of management Sofia, 16 Iliensko Shosse Str., UIC 831902088, LEI code 097900BGGW0000048796, pursuant to Art. 89t of LPOS, notifies all shareholders of the company and all interested parties regarding the start of an initial public offering of warrants. The warrants have ISIN BG9200001212. The prospectus was approved with decision № 804 - Е of 04.11.2021 of the Financial Supervision Commission. All interested parties can get acquainted with the prospectus on the FSC website, on the website of “Sopharma” AD (www.sopharmagroup.com), on the website of the investment intermediary “MK Brokers” AD (https://www.mkb.bg/) and on www.x3news.com. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_2021_Warrants_117_espi.pdf SFA_2021_Warrants_117_espi.pdf | Notification under Art. 89t of LPOS regarding public offering of warrants by “Sopharma” AD | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2021-11-05 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.1 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
